Mechanism of Action
Transmembrane Beta-Helix Ion Channel
Gramicidin A adopts a unique right-handed beta-6.3 helix in membranes (not an alpha-helix). Two gramicidin A molecules dimerize head-to-head in the membrane, forming a continuous pore spanning the bilayer. The channel pore has ~4 angstrom diameter and is lined by carbonyl oxygens from the peptide backbone. This channel is highly selective for monovalent cations (H+ > K+ > Na+), allowing their passive transport down concentration gradients. The resulting collapse of membrane potential kills bacteria but also lyses mammalian erythrocytes, explaining topical-only use.
Model System for Membrane Biology
Beyond its antibiotic use, gramicidin A has been studied for 50+ years as a structural model for transmembrane ion channels. The ability to reconstitute gramicidin A channels in synthetic lipid bilayers at precise concentrations and characterize them by single-channel electrophysiology has made it a gold standard for studying channel conductance, selectivity, lipid-channel interactions, and the effects of membrane composition on channel activity. These studies inform understanding of all biological ion channels.
Research Summary
Neosporin and Topical Use
ApprovedGramicidin is included in Neosporin (neomycin/polymyxin B/gramicidin combination) and many other topical antibiotic products. The combination provides activity against Gram-positive bacteria (gramicidin), Gram-negative bacteria (polymyxin B), and a broad spectrum (neomycin). Clinical evidence supports efficacy for minor skin wounds, burns, and eye infections. Gramicidin-containing eye drops are used for bacterial conjunctivitis in some countries.
Resistance Resistance of Ion Channel Mechanism
PreclinicalUnlike enzyme-inhibiting antibiotics where single point mutations can cause resistance, resistance to gramicidin A requires fundamental changes in membrane lipid composition that alter channel formation and stability. Clinically significant resistance to gramicidin in topical use is rare despite decades of widespread application, supporting the theoretical resistance-resistance of the membrane-disrupting/channel-forming mechanism.
Calculate your Gramicidin A dose Vial strength, BAC water, exact syringe draw in IU. Free, no signup. Open Calc →
Research Protocols
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Topical antiseptic (approved) | Component of Neosporin at ~0.025 mg/g | Up to 3x daily | Topical skin/eye |
| Ion channel research | Nanomolar to nanomolar concentrations | Continuous | Lipid bilayer electrophysiology |
Systemic use is absolutely contraindicated due to hemolytic toxicity.
Interactions
Safety Profile
Excellent topical safety record from decades of Neosporin use. Hemolytic toxicity makes systemic administration absolutely contraindicated. Contact sensitization to neomycin (the aminoglycoside partner) is common; gramicidin itself is rarely sensitizing. Ophthalmic use in formulations is well tolerated. Keep away from IV use or application to large open wounds with systemic absorption risk.
References
- [1]Hotchkiss RD and Dubos RJ. (1940). Fractionation of the bactericidal agent from cultures of a soil bacillus. J Biol Chem, 136(3), 803-804.
- [2]Andersen OS and Koeppe RE. (2007). Bilayer thickness and membrane protein function: an energetic perspective. Annu Rev Biophys Biomol Struct, 36, 107-130.